Rituximab treatment of myasthenia gravis: A systematic review

Maintenance immunosuppression in myasthenia gravis

(2016) Lauren Gotterer et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

International consensus guidance for management of myasthenia gravis

(2016) Donald B. Sanders et al.   NEUROLOGY

Randomized Trial of Thymectomy in Myasthenia Gravis

(2016) Gil I. Wolfe et al.   NEW ENGLAND JOURNAL OF MEDICINE

Efficacy of Rituximab for Pemphigus: A Systematic Review and Meta-analysis of Different Regimens

(2015) H Wang et al.   ACTA DERMATO-VENEREOLOGICA

The role of rituximab in adults with warm antibody autoimmune hemolytic anemia

(2015) D. Dierickx et al.   BLOOD

Drug-induced progressive multifocal leukoencephalopathy: Lessons learned from contrasting natalizumab and rituximab

(2015) NS Vermeer et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Efficacy and safety of rituximab in Japanese patients with relapsed chronic immune thrombocytopenia refractory to conventional therapy

(2015) Yoshitaka Miyakawa et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Selective response to rituximab in a young child with MuSK-associated myasthenia gravis

(2015) Raghav Govindarajan et al.   NEUROMUSCULAR DISORDERS

Anti-B-Cell Therapies in Autoimmune Neurological Diseases: Rationale and Efficacy Trials

(2015) Harry Alexopoulos et al.   Neurotherapeutics

Current Treatment, Emerging Translational Therapies, and New Therapeutic Targets for Autoimmune Myasthenia Gravis

(2015) Jeffrey T. Guptill et al.   Neurotherapeutics

Natalizumab: Risk Stratification of Individual Patients with Multiple Sclerosis

(2014) Carmen Tur et al.   CNS DRUGS

Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial

(2014) Kazumoto Iijima et al.   LANCET

Comparison of Plasmapheresis and Intravenous Immunoglobulin as Maintenance Therapies for Juvenile Myasthenia Gravis

(2014) Wendy K. M. Liew et al.   JAMA Neurology

Systemic Inflammatory Pseudotumor and Myasthenia Gravis

(2014) Marc H. Levin et al.   JAMA Ophthalmology

Pathophysiology of myasthenia gravis with antibodies to the acetylcholine receptor, muscle-specific kinase and low-density lipoprotein receptor-related protein 4

(2013) Jan J.G.M. Verschuuren et al.   AUTOIMMUNITY REVIEWS

Rituximab for Non-Hodgkin's Lymphoma: A Story of Rapid Success in Translation

(2013) Andrew M. Harrison et al.   CTS-Clinical and Translational Science

Changes in regulatory T cells after rituximab in two patients with refractory myasthenia gravis

(2013) Valentina Catzola et al.   JOURNAL OF NEUROLOGY

Long-term benefit of rituximab in MuSK autoantibody myasthenia gravis patients: Table 1

(2013) Benison Keung et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Prolonged B-Cell Depletion in MuSK Myasthenia Gravis Following Rituximab Treatment

(2013) John S. Yi et al.   MUSCLE & NERVE

Interleukin-10 producing-B cells and their association with responsiveness to rituximab in myasthenia gravis

(2013) Feng Sun et al.   MUSCLE & NERVE

Does change in acetylcholine receptor antibody level correlate with clinical change in myasthenia gravis?

(2013) Donald B. Sanders et al.   MUSCLE & NERVE

Myocardial infarction after rituximab infusion

(2013) Dimitri Renard et al.   NEUROMUSCULAR DISORDERS

Efficacy of Remission-Induction Regimens for ANCA-Associated Vasculitis

(2013) Ulrich Specks et al.   NEW ENGLAND JOURNAL OF MEDICINE

Successful treatment of severe myasthenia gravis developed after allogeneic hematopoietic stem cell transplantation with plasma exchange and rituximab

(2013) Sule Unal et al.   PEDIATRIC BLOOD & CANCER

Muscle autoantibodies in myasthenia gravis: beyond diagnosis?

(2012) Matthew N Meriggioli et al.   Expert Review of Clinical Immunology

Rituximab in refractory and non-refractory myasthenia: A retrospective multicenter study

(2012) Nicolas Collongues et al.   MUSCLE & NERVE

Rituximab therapy for morvan syndrome associated with myasthenia gravis

(2012) Michael Weiss   MUSCLE & NERVE

Myasthenia gravis, castleman disease, pemphigus, and anti-phospholipid syndrome

(2012) Michala Jakubíková et al.   MUSCLE & NERVE

Long-lasting treatment effect of rituximab in MuSK myasthenia

(2012) J. Diaz-Manera et al.   NEUROLOGY

Rituximab in Severe Seronegative Juvenile Myasthenia Gravis: Review of the Literature

(2012) Roshan Koul et al.   PEDIATRIC NEUROLOGY

Myasthenia gravis, an autoimmune manifestation of lymphoma and lymphoproliferative disorders: case reports and review of literature

(2011) Kourosh Rezania et al.   LEUKEMIA & LYMPHOMA

Rituximab is successful in an HIV-positive patient with MuSK myasthenia gravis

(2011) T. Kuntzer et al.   NEUROLOGY

Comparison of IVIg and PLEX in patients with myasthenia gravis

(2011) D. Barth et al.   NEUROLOGY

Response of patients with refractory myasthenia gravis to rituximab: a retrospective study

(2011) Richard J. Nowak et al.   Therapeutic Advances in Neurological Disorders

Rituximab for severe myasthenia gravis - experience from five patients

(2010) C. Lindberg et al.   ACTA NEUROLOGICA SCANDINAVICA

Update on muscle-specific tyrosine kinase antibody positive myasthenia gravis

(2010) Jeffrey T Guptill et al.   CURRENT OPINION IN NEUROLOGY

Myasthenia gravis developing in a patient with CNS lymphoma

(2010) Rami Masroujeh et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Rituximab in the treatment of three coexistent neurological autoimmune diseases: chronic inflammatory demyelinating polyradiculoneuropathy, Morvan syndrome and myasthenia gravis

(2010) A. Sadnicka et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Use and monitoring of low dose rituximab in myasthenia gravis

(2010) S. Blum et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

The use of rituximab in myasthenia gravis and Lambert-Eaton myasthenic syndrome

(2010) P. Maddison et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Rituximab pharmacokinetics during the management of acute idiopathic thrombotic thrombocytopenic purpura

(2010) V. MCDONALD et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis

(2010) John H. Stone et al.   NEW ENGLAND JOURNAL OF MEDICINE

Allogeneic Hematopoietic Cell Transplantation for Refractory Myasthenia Gravis

(2009) Jonathan Strober et al.   ARCHIVES OF NEUROLOGY

Rituximab for myasthenia gravis

(2009) Karl Stieglbauer et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Rituximab in the management of refractory myasthenia gravis

(2009) Nazlee Zebardast et al.   MUSCLE & NERVE

Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function

(2009) Mark D. Pescovitz et al.   NEW ENGLAND JOURNAL OF MEDICINE

Response to Therapy in Myasthenia Gravis with Anti-MuSK Antibodies

(2008) Amelia Evoli et al.   Annals of the New York Academy of Sciences

Prolonged B-cell depletion following rituximab therapy in systemic lupus erythematosus: a report of two cases

(2008) T Y-T Lu et al.   ANNALS OF THE RHEUMATIC DISEASES

Variability in the biological response to anti-CD20 B cell depletion in systemic lupus erythaematosus

(2008) D Albert et al.   ANNALS OF THE RHEUMATIC DISEASES

Successful treatment of refractory generalized myasthenia gravis with rituximab

(2008) C. Lebrun et al.   EUROPEAN JOURNAL OF NEUROLOGY

Sustained response to Rituximab in anti-AChR and anti-MuSK positive Myasthenia Gravis patients

(2008) Isabel Illa et al.   JOURNAL OF NEUROIMMUNOLOGY

Improvement with rituximab in a patient with both rheumatoid arthritis and myasthenia gravis

(2008) Samar Kerkeni et al.   MUSCLE & NERVE

A trial of mycophenolate mofetil with prednisone as initial immunotherapy in myasthenia gravis

(2008)   NEUROLOGY

An international, phase III, randomized trial of mycophenolate mofetil in myasthenia gravis

(2008) D. B. Sanders et al.   NEUROLOGY

Methotrexate-associated mantle-cell lymphoma in an elderly man with myasthenia gravis

(2008) Huy Tran et al.   Nature clinical practice. Oncology